Jiangsu Rayson Biotech Co., Ltd. was founded in 2013 and is located in the Science and Technology Park of the National High-tech Development Zone in Xuzhou City, Jiangsu Province, a scenic area. It has built a Class 10,000 cleanroom-grade GMP-standard constant-temperature and constant-humidity production workshop and R&D laboratory. Rayson Biotech is dedicated to the research, development and production of immunodiagnostic rapid test reagents (POCT), mainly providing qualitative and quantitative rapid test kits based on immunochromatography and quantitative analysis instruments, with product categories covering human clinical, pet, livestock and poultry, food safety and other markets. Rayson Biotech is also committed to providing customers with comprehensive integrated solutions for disease diagnosis and treatment. The company owns its own brand "RAYSONBIO", and its products are exported to international markets. Rayson Biotech has a reasonably structured R&D and production team, takes "pursuing excellence, delivering health" as its mission, is committed to the development of new products, and continuously improves the technological content of new products. It has established cooperative relationships with a number of well-known biotechnology companies at home and abroad. Rayson Biotech has built a complete R&D and production system for genetically engineered proteins and antibody preparation, and has prepared genetically engineered proteins and antibodies for a variety of major animal diseases for use in the R&D and production of rapid immunodiagnostic reagents, and has so far obtained a number of authorized national patents. The company has a marketing team with high professional standards, a pioneering spirit, rich clinical experience and full of vitality, which is customer-centered and has won customer praise with high-quality products and first-class services. Rayson Biotech will continue to be driven by scientific and technological progress, rely on high and new technologies, and be guided by outstanding talent, striving to become an internationally competitive biotechnology enterprise and endeavoring to write a new chapter for the medical cause.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows